| Literature DB >> 34540152 |
Mohammad Masoud Emami Meybodi1, Abbas Rahimi Foroushani2, Masoome Zolfaghari1, Alireza Abdollahi3, Abbas Alipour4, Esmaeil Mohammadnejad5, Ehsan Zare Mehrjardi6, Arash Seifi1.
Abstract
BACKGROUND AND OBJECTIVES: Antimicrobial resistance (AMR) is an increasing threat for efficient treatment of infections. Determining the epidemiology of healthcare-associated infections and causative agents in various hospital wards helps appropriate selection of antimicrobial agents.Entities:
Keywords: Cross infection; Drug resistance; Escherichia coli; Klebsiella pneumoniae; Methicillin-resistant Staphylococcus aureus; Vancomycin resistant Enterococci
Year: 2021 PMID: 34540152 PMCID: PMC8408023 DOI: 10.18502/ijm.v13i2.5978
Source DB: PubMed Journal: Iran J Microbiol ISSN: 2008-3289
Association between antimicrobial resistance and different variables.
|
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
| ||||||
| Age (year) | 46.14 (23.06) | 47.67 (24.12) | 0.65 | 50.43 (21.75) | 54.22 (21.06) | 0.64 | 48.69 (24.3) | 56.45 (18.53) | 0.004 | 51 (19.17) | 54 (17.48) | 0.41 | |
| Time of detection | 15.44 (23.47) | 23.25 (25.72) | 0.02 | 25 (34.24) | 20.51 (18.49) | 0.54 | 13.76 (24.69) | 14.35 (25.30) | 0.85 | 13.63 (14.22) | 19.2 (22.63) | 0.18 | |
| Length of stay | 33.15 (52.78) | 37.66 (29.6) | 0.37 | 38.43 (30.34) | 35.4 (20.93) | 0.71 | 27.63 (46.05) | 24.5 (25.09) | 0.48 | 27.34 (13.34) | 35.54 (27.85) | 0.08 | |
| Gender | Male | 26 (40.6) | 126 (50.6) | 0.15 | 4 (57.1) | 114 (60.6) | 0.85 | 41 (36.9) | 56 (36.8) | 0.98 | 27 (71.1) | 32 (65.3) | 0.56 |
| Female | 38 (59.4) | 123 (49.4) | 3 (42.9) | 74 (39.4) | 70 (63.1) | 96 (63.2) | 11 (28.9) | 17 (34.7) | |||||
| Ward | Internal medicine wards | 34 (53.1) | 52 (20.9) | 0.00 | 3 (42.9) | 20 (10.6) | 0.06 | 52 (46.8) | 63 (41.4) | 0.44 | 15 (39.5) | 17 (34.7) | 0.02 |
| Surgery wards | 16 (25) | 39 (15.7) | 0 | 15 (8) | 30 (27%) | 35 (23) | 13 (34.2) | 7 (14.3) | |||||
| ICUs wards | 9 (14.1) | 120 (48.2) | 4 (57.1) | 134 (71.3) | 18 (16.2) | 35 (23) | 7 (18.4) | 23 (46.9) | |||||
| Transplant wards | 5 (7.8) | 38 (15.3) | 0 | 19 (10.1) | 11 (9.9) | 19 (12.5) | 3 (7.9) | 2 (4.1) | |||||
| Outcome | Discharged | 92 (82.9) | 126 (82.9) | 0.95 | 5 (71.4) | 90 (47.9) | 0.44 | 92 (82.9) | 126 (82.9) | 0.95 | 32 (84.2) | 38 (77.6) | 0.29 |
| Deceased | 16 (14.4) | 21 (13.8) | 2 (28.6) | 90 (47.9) | 16 (14.4) | 21 (13.8) | 6 (15.8) | 8 (16.3) | |||||
| Still hospitalised | 3 (2.7) | 5 (3.3) | 0 | 8 (4.3) | 3 (2.7) | 5 (3.3) | 0 | 3 (6.1) | |||||
Extended spectrum beta-lactamases (ESBL) ; S: Susceptible; R: Resistant
Methicillin-resistant S. aureus (MRSA)